[ORGANIZATION]

tozorakimab

Featured in 1 tracked story · first seen 3 days ago

Situations

[ACTIVE] [HEALTH] [ES] [IT] [US]

AstraZeneca tozorakimab COPD clinical trials

2 clusters · 16 sources · last updated about 5 hours ago

Latest: AstraZeneca reports 30% reduction in COPD exacerbations with tozorakimab

AstraZeneca has reported positive results from two Phase 3 clinical trials, OBERON and TITANIA, regarding its experimental monoclonal antibody, tozorakimab, for the treatment of chronic obstructive pulmonary disease (COP